Human breast MCF7 cancer cells are commonly used for studying the biology and drug resistance development process (e.g., SERM resistance) of ER+ breast cancer (Comşa et al., 2015; Huang et al., 2017). This evidence concerns the gene ESR1 and breast cancer.